Neurotoxic aspects of porphyrinopathies: lead and succinylacetone.
D000624:5-Aminolevulinate Synthetase / Q000037:antagonists & inhibitors; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D006418:Heme / Q000096:biosynthesis*; D006537:Heptanoates / Q000633:toxicity*; D006538:Heptanoic Acids / Q000633:toxicity*; D007854:Lead / Q000633:toxicity*; D011164:Porphyrias / Q000378:metabolism*; D051381:Rats; D012640:Seizures / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D006537:Heptanoates; D006538:Heptanoic Acids; D007854:Lead; D006418:Heme; C020804:succinylacetone; D005680:gamma-Aminobutyric Acid; D000624:5-Aminolevulinate Synthetase